From: Risk factors to predict drug-resistant pathogens in hemodialysis-associated pneumonia
Total (N = 530) | HD(N = 48) | Non-HD (N = 482) | p | |
---|---|---|---|---|
Age(years) | 75.1 ± 12.8 | 68.3 ± 11.3* | 75.8 ± 12.8 | <0.001 |
Sex(M/F) | 349/181 | 25/23 | 326/156 | |
PSI | 129.6 ± 33.5 | 116.8 ± 34.9 | 130.8 ± 33.2 | |
PSI group | 0.008 | |||
PSI II | 15(2.8) | 4(8.3) | 11(2.3) | |
PSI III | 51(9.6) | 11(22.3)* | 40(8.3) | |
PSI IV | 195(36.8) | 14(29.2)* | 181(37.6) | |
PSI V | 269(50.8) | 19(39.6)* | 250(51.9) | |
ICU n(%) | 116 (21.9) | 7(14.6) | 109(22.6) | 0.2 |
Admission within 90 d n(%) | 317(59.8) | 14(29.2)* | 303(62.9) | <0.005 |
Nursing home n(%) | 224 (42.3) | 10(20.8)* | 214(44.4) | 0.002 |
Antibiotics within 90 d n(%) | 232 (43.8) | 13(27.1)* | 219(45.4) | 0.015 |
Active chemotherapy n(%) | 47 (8.9) | 0* | 47(9.8) | 0.024 |
Steroid use n(%) | 63(11.9) | 0* | 63(13.1) | 0.008 |
Wound care n(%) | 103 (19.4) | 11(22.9) | 92(19.1) | 0.528 |
CVA n(%) | 264 (49.8) | 13(27.1)* | 251(52.1) | 0.001 |
Malignancy n(%) | 140(26.4) | 5(10.4)* | 135(28.2) | 0.008 |
DM n(%) | 220 (41.5) | 34(70.8)* | 186(38.6) | <0.005 |
Heart failure n(%) | 84(15.8) | 9(18.8) | 75(15.6) | 0.564 |
COPD n(%) | 191(36) | 11(22.9)* | 180(37.3) | 0.047 |
Liver cirrhosis | 20 (3.8) | 0 | 20(4.1) | 0.151 |